NuÑez, Gilbert .

HRN: 24-14-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/16/2025
CO-AMOXICLAV 457MG/5ML, 70ML SUSPENSION (BOT)
07/16/2025
07/20/2025
PO
2 Ml
Q 12
PCAP-B
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines